| Medical and Health Sciences | Lifetime | 937 | US 485 | 99.96 |
| Pulmonary and Respiratory Medicine | Lifetime | 117 | US 64 | 99.85 |
| Rheumatology | Lifetime | 43 | US 15 | 99.79 |
| Medical Physiology | Lifetime | 777 | US 395 | 98.59 |
| Pathology and Forensic Medicine | Lifetime | 854 | US 390 | 95.87 |
| Medical Genetics | Lifetime | 635 | US 312 | 93.25 |
| Nephrology | Lifetime | 757 | US 347 | 88.76 |
| Dermatology | Lifetime | 988 | US 400 | 84.67 |
| Ophthalmology | Lifetime | 859 | US 401 | 69.84 |
| Rehabilitation | Lifetime | 948 | US 353 | 62.69 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 238 | US 74 | 98.05 |
| Rheumatology | 2021-2025 | 354 | US 112 | 86.56 |
| Vasculitis and related conditions | Lifetime | 6 | US 4 | 99.85 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 10 | US 4 | 99.70 |
| Systemic Lupus Erythematosus Research | Lifetime | 44 | US 14 | 99.72 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | Lifetime | 34 | US 18 | 99.68 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 6 | US 2 | 99.74 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 36 | US 12 | 99.79 |
| Systemic Sclerosis and Related Diseases | Lifetime | 76 | US 28 | 99.18 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 82 | US 36 | 98.93 |
| Urticaria and Related Conditions | Lifetime | 112 | US 40 | 98.77 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 143 | US 45 | 98.93 |
| Eosinophilic Disorders and Syndromes | Lifetime | 195 | US 94 | 98.37 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 175 | US 78 | 97.67 |
| Renal Diseases and Glomerulopathies | Lifetime | 505 | US 178 | 97.65 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 210 | US 83 | 97.06 |
| Medicine and Dermatology Studies History | Lifetime | 178 | US 81 | 93.87 |
| Biosimilars and Bioanalytical Methods | Lifetime | 531 | US 200 | 92.49 |
| Salivary Gland Disorders and Functions | Lifetime | 747 | US 235 | 93.23 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 523 | US 159 | 91.60 |
| Spondyloarthritis Studies and Treatments | Lifetime | 808 | US 142 | 92.96 |
| Abdominal vascular conditions and treatments | Lifetime | 882 | US 367 | 87.89 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 639 | US 279 | 86.03 |
| History of Medicine Studies | Lifetime | 965 | US 344 | 67.29 |
| Historical Medical Research and Treatments | Lifetime | 680 | US 280 | 59.64 |
| Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis | 2021-2025 | 96 | US 30 | 98.01 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 65 | US 23 | 96.02 |
| Systemic Sclerosis and Related Diseases | 2021-2025 | 175 | US 30 | 94.40 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 201 | US 99 | 91.35 |
| Vasculitis and related conditions | 2021-2025 | 238 | US 34 | 92.32 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 189 | US 54 | 90.84 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 434 | US 86 | 83.91 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 477 | US 71 | 65.70 |
